LENZ Therapeutics - 53 Year Dividend History | LENZ
Historical dividend payout and yield for LENZ Therapeutics (LENZ) since 1971. The current TTM dividend payout for LENZ Therapeutics (LENZ) as of November 01, 2024 is $0.00. The current dividend yield for LENZ Therapeutics as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.768B |
$0.000B |
|
Lenz Therapeutics Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision. Its product candidate includes LNZ100 and LNZ101, are preservative-free, single-use, once-daily, aceclidine-based eye drops currently in Phase 3 clinical trials for the treatment of presbyopia. Lenz Therapeutics Inc., formerly known as Graphite Bio Inc., is based in SOUTH SAN FRANCISCO, Calif.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
